Table 3.
Concentrations of albumins, transferrin and transthyretin in the study participants.
| Analyzed Marker | Study Group | Statistical Parameters | p-Value * | ||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Median | Q1–Q3 | Min.–Max. | |||
| Albumins (mg/mL) |
CD | 26.42 | 25.25 | 15.75 | 7.90–46.95 | 0.44–109.50 | <0.0001 ** |
| UC | 38.96 | 34.07 | 32.70 | 12.90–53.40 | 0.80–163.30 | ||
| Control | 78.40 | 87.74 | 43.20 | 12.10–101.90 | 8.90–266.70 | ||
| Transferrin (mg/mL) |
CD | 3.21 | 3.75 | 1.32 | 8.85–5.00 | 0.15–14.01 | =0.3548 |
| UC | 2.70 | 2.91 | 1.55 | 0.94–3.34 | 0.18–10.85 | ||
| Control | 4.22 | 3.57 | 1.90 | 1.60–8.34 | 0.46–0.85 | ||
| Transthyretin (ng/mL) |
CD | 3.14 | 2.48 | 3.02 | 2.51–3.34 | 0.52–19.20 | =0.0001 ** |
| UC | 2.83 | 1.22 | 2.82 | 2.56–3.11 | 0.27–8.20 | ||
| Control | 1.32 | 0.56 | 1.40 | 0.94–1.66 | 0.37–2.24 | ||
* Statistical significance for the model used. All between-group comparisons were controlled for the patients’ age and gender. ** Post hoc multiple comparisons. Albumins: CD vs. UC, p = 0.0414; UC vs. controls, p = 0.0001; CD vs. controls, p = 0.0060. Transthyretin: CD vs. UC, p = 0.7745; UC vs. controls, p = 0.0048; CD vs. controls, p = 0.0003.